Suppression of the Argininosuccinase Acid Lyase Gene by Mutant Huntingtin with Polyglutamine Expansion

Y Chern,MC Chiang,HM Chen
DOI: https://doi.org/10.1096/fasebj.20.5.a1340-d
2006-01-01
Abstract:Huntington¡¦s disease (HD) is a late‐onset neurodegenerative disease. The causative mutation is a CAG trinucleotide expansion in the exon 1 of Huntingtin (Htt) gene. Mutant Htt with polyglutamine (polyQ) expansion may alter transcription by squelching transcription factors. We herein report that mutant Htt suppressed the expression of argininosuccinase acid lyase (AL). Quantitative PCR and Western blot analyses revealed that the transcript and protein levels of liver AL in R6/2 mice (a transgenic mouse model of HD) were markedly reduced when compared to those of wildtype mice. Expression of the mutant Htt markedly reduced the AL promoter activity. Mutation of the CCAAT site located in the promoter region of the AL gene led to lower promoter activity which could not be further suppressed by mutant Htt. Using EMSA analyses, we also demonstrated that C/EBPa and its cofactor (CBP) bind to the AL promoter at the CCAAT site. Mutations of the CCAAT site completely eliminated the binding. In the presence of mutant Htt, CBP was no longer bound to the AL promoter while C/EBPa remained on the CCAAT site. The binding of C/EBPa and CBP to the AL promoter was further verified by using a combination of EMSA and Western blot analyses. Moreover, The transcript and protein levels of C/EBPa in the liver of R6/2 mice were significantly lower than those in wildtype mice. Collectively, mutant Htt suppressed the functions of C/EBPa at multiple levels and might contribute to the disease progression of HD.
What problem does this paper attempt to address?